Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
06. Oktober 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase...
Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell™
20. August 2020 13:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS...